When discussing weight loss medicines, it is helpful to ask your GP or specialist about: Currently licensed and NICE-approved options available to you on the NHS or privately Eligibility criteria for specific treatments and what monitoring would be required Realistic expectations regarding weight loss outcomes, timescales, and the importance of lifestyle changes alongside medication Potential side effects , including gastrointestinal symptoms commonly associated with GLP-1 receptor agonists, and how these are managed If you experience any suspected side effects from a weight management medicine, you can report these directly to the MHRA via the Yellow Card Scheme (available at yellowcard.mhra.gov.uk)
Conversely, some studies have found no relationship between B12 deficiency and sensorimotor symptoms, indicating that neurological findings are not always similar across studies
Tirzepatide also suppresses appetite and affects metabolism, while naltrexone's effects are usually mild and short-lived
For most statins, which are taken daily and have relatively predictable absorption profiles, this effect is not considered clinically significant
The PlexusDx Precision Peptide Genetic Test reveals which pathway your genes favor, optimizing your choice from the start
Hims, a telehealth company that sells direct-to-consumer finasteride and GLP-1s, has signaled that it will move to sell the controversial substances should they be approved after acquiring a peptide manufacturing facility in 2025